Slide 1: FY 2019 Results Presentation
pro+medicus OUR SUPPORT. YOUR SUCCESS. FY 2019 RESULTS PRESENTATION AUGUST 2019 VISAGE IMAGING:
Slide 2: Pro Medicus (ASX:PME)
PRO MEDICUS (ASX:PME) Healthcare IT company specializing in Enterprise Imaging and Radiology Information System (RIS) software. Leading edge products, growing global presence. EU HQ/R&D Berlin GmbH U.S. HO San Diego CA wd GROUP HO Melbourne AUS % VISAGE TMAGING" 2
Slide 3: Visage Product Suite
VISAGE RIS ©) ASX:PME pro+medicus.net @B VISAGE? Pd | OEM VISAGE 7 OEM PRODUCT SUITE prosmedicu % ners ie, Visace IMAGING:
Slide 4: Results
RESULTS HY 2019 $50.1M § aan | $19.1M $22.7M 51.6% Profit 0 Underlying EBIT ($) se (% ie” (ell) $32.3M Cash ® Company Strong debt balance up 28.0% free sheet $0.045 Fully franked Final dividend Total dividend up 75% Reserves prosmedicus & founsupront your success VISAGE TMAGING’
Slide 5: FY2019 in Review
A , IN REVIEW é FY2019 =arle PARTNERS —, : VA @ Ui Depertment Gg DukeHealth PARTNERS ses —==__»> $5M/7 $27M/ al $4M/ $14M/ Mae even Health years 7 years $3M 5 years 7 years a New New German Govt. Hospital VISN23 New On/Ahead Strong Contract Contract Contract Extension Contract (Renewal) Contract of
Slide 6: Operational (Transaction) Model
y OPERATONAL (TRANSACTION) MODEL Used in vast majority of US contracts Delivered as SaaS model Now used in RIS contracts in AUS Model based on quaranteed transaction minimums Contracted revenue > AS180M/5 years* Upside as client examination volumes grow Annuity style revenue stream — greater predict
Slide 7: Exam (Transaction) Revenue
YY EXAM (TRANSACTION) REVENUE / 9 ¢ Recurring in nature ° Increased by 43.5% YoY * Growth to continue in FY 2020 onwards (Partners, Duke & others) * Growth from existing clients (organic and M&A) plus new clients : ¢ Further upside with adoption of new products A (VISAGE 7 Open Archive and Enterpris
Slide 8: Professional Services
A VV PROFESSIONAL SERVICES Vv ¢ Project planning, training & implementation -—————— [ol * Revenue spread over the length of the contract Q A - new accounting standards (AASB 15) L ° Recurring in nature ~ 10% contract value oo i } e Will decrease as a % of total revenue as exam 0 y (transaction) reve
Slide 9: Revenue by type FY15-FY19
$60,000,000 Exam/licence revenue*** Support/baseline revenue*** Capital revenue (net of hardware) Professional Services (new revenue standard)*** ***Recurring revenue $50,000,000 $6,464,000 $3,049,000 $40,000,000 $12,327,000 $4,151,000 $30,000,000 $2,429,000 $10,858,000 $1,445,000 $10,117,000 $20,00
Slide 10: Operating Leverage
OPERATING LEVERAGE ¢ Highly scalable offering ed * No capex (HW) - SW only model S ° Training & Installation - charged as professional | services s ¢ Relatively fixed cost base * High operating leverage ¢ Margin continues to grow as footprint increases te $$ prosmedicus | % founsupront your success
Slide 11: Margin Expansion
MARGIN EXPANSION - | EBIT Margins a — <. FY-14 FY-15 FY-16 FY-17 FY-18 FY-19
Slide 12: Partners HealthCare
PARTNERS HEALTHCARE Largest health system in Massachusetts Massachusetts General Hospital ranked (#2) and Brigham and Women's Hospital (#13) best hospital in US Top two teaching hospitals for Harvard Medical School Leader in biomedical and data science research — renowned MGH & BWH Center for Clinic
Slide 13: Partners HealthCare
PARTNERS HEALTHCARE ¢ 7-year, $27M deal, transaction-based licensing model ¢ Largest contract in the history of PME ¢ VISAGE ? cornerstone of the Partners Radiology Enterprise Platform (PREP) ¢ Transformational - a key component of Partners 2.0 initiative prosmedicu % ners ie, Visace IMAGING: 13
Slide 14: Partners HealthCare
PARTNERS HEALTHCARE Phase 1 ¢ Massachusetts General Hospital and Brigham and Women's Hospital ¢ |mplemented in record time ° Project over 95% complete Phase 2 ¢ Other hospitals in Partners HealthCare network * Implementation following completion of Phase 1 % ors VISAGE TMAGING' 14
Slide 15: Duke Health
DUKE HEALTH ° 7year- $14M deal ¢ Largest health system in North Carolina ¢ Visage 7 to be implemented across all of Duke's radiology ——— departments ¢ Transaction-based model with potential upside ¢ Adds to PME's growing footprint in the tier 1 U.S. academic hospital segment % ors VISAGE TMAGING' 15
Slide 16: Implementations
4 VV IMPLEMENTATIONS On/Ahead Continues Completed under 25% of Continues of schedule to deliver the industry norm to deliver All Implementations Fast Track Methodology Large Scale Projects Huge Savings to the Client Frees Up Staff Reduced Key Differentiator Barrier to Change Ability to do Other Jobs
Slide 17: Visage - Proven ROI
: % ry VISAGE - PROVEN ROI VisAce IMAGING: >. Significant IT & Unparalleled Increase in Greater Clinical Infrastructure Savings Radiologist Efficiency Accuracy Vv Improved Physician Delivers Superior y Engagement Value Proposition prosmedicus | 4 founsupront your success VISAGE IMAGING’ 17
Slide 18: Prospects
6) Prospects V Network Effect A Opportunities A At various stages of the cycle From recent high profile wins Increasing number coming to market Pipeline Robust In terms of quality and quantity of opportunities prosmedicus | 4 founsupront your success VISAGE IMAGING’ 18
Slide 19: Artificial Intelligence Visage AI
4 vv ARTIFICIAL INTELLIGENCE 6 VISAGE ‘Al ¢ Healthcare imaging ideally suited to Al ¢ Visage well positioned to take advantage of this emerging technology Vv ¢ Advanced image processing in © | A healthcare is “in our DNA” ¢ VISAGE ? architecture based on GPU -~ 4 A technology used in Al (6 4) ZF ER
Slide 20: Artificial Intelligence (cont.)
4 VV ARTIFICIAL INTELLIGENCE (cont. ) y 6 VISAGE ‘Al ¢ "In product” Al - automated high-end functions within VISAGE 7 ic / e VISAGE 7 Al single visualization — V platform for both the clinical AND ® research environments A * VISAGE 7 Al - Open platform enables _ A integration of 3 party algorithms (
Slide 21: Summary
SUMMARY ¢ Growing North American footprint ¢ Transaction revenue up 43.5% compared to FY2018 ¢ Market leading technologies ¢ Proven implementation & support capability * Unparalleled value proposition (Clinical and Financial ROI) ¢ 1% Jarge scale VISAGE 7 Open Archive in U.S. ¢ New Product - Enterpr
Slide 22: a) f=) > << = <o - kt
a) f=) > << = <o - kt